Literature DB >> 27153320

A revolutionary therapeutic approach for psoriasis: bispecific biological agents.

T Torres1, M Romanelli2, A Chiricozzi2.   

Abstract

Entities:  

Keywords:  ABT-122; ALX-0761; AZ17; Bimekizumab; COVA322; Psoriasis; bispecific antibodies

Mesh：

Substances：

Year:  2016        PMID： 27153320     DOI： 10.1080/13543784.2016.1187130

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN： 1354-3784            Impact factor:   6.206


× No keyword cloud information.
  15 in total

1.  Combined Blockade of TNF-α and IL-17A Alleviates Progression of Collagen-Induced Arthritis without Causing Serious Infections in Mice.

Authors:  Fang Shen; Akash H Verma; Amy Volk; Brian Jones; Bianca M Coleman; Matthew J Loza; Ravi Malaviya; Beverley Moore; Daniel Weinstock; M Merle Elloso; Sarah L Gaffen; Tatiana Ort
Journal:  J Immunol       Date:  2019-02-11       Impact factor: 5.422

Review 2.  Novel Biologic Agents Targeting Interleukin-23 and Interleukin-17 for Moderate-to-Severe Psoriasis.

Authors:  Zeyu Chen; Yu Gong; Yuling Shi
Journal:  Clin Drug Investig       Date:  2017-10       Impact factor: 2.859

Review 3.  Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.

Authors:  Ya-Chu Tsai; Tsen-Fang Tsai
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-06       Impact factor: 5.346

Review 4.  The IL-17 Family of Cytokines in Health and Disease.

Authors:  Mandy J McGeachy; Daniel J Cua; Sarah L Gaffen
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

Review 5.  Psoriasis pathogenesis and the development of novel targeted immune therapies.

Authors:  Jason E Hawkes; Tom C Chan; James G Krueger
Journal:  J Allergy Clin Immunol       Date:  2017-09       Impact factor: 10.793

Review 6.  Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis.

Authors:  Jason E Hawkes; Bernice Y Yan; Tom C Chan; James G Krueger
Journal:  J Immunol       Date:  2018-09-15       Impact factor: 5.422

7.  VHH-Based Bispecific Antibodies Targeting Cytokine Production.

Authors:  Maxim A Nosenko; Kamar-Sulu N Atretkhany; Vladislav V Mokhonov; Grigory A Efimov; Andrey A Kruglov; Sergei V Tillib; Marina S Drutskaya; Sergei A Nedospasov
Journal:  Front Immunol       Date:  2017-09-01       Impact factor: 7.561

Review 8.  Bispecific antibodies: design, therapy, perspectives.

Authors:  Sergey E Sedykh; Victor V Prinz; Valentina N Buneva; Georgy A Nevinsky
Journal:  Drug Des Devel Ther       Date:  2018-01-22       Impact factor: 4.162

9.  Bimekizumab: the new drug in the biologics armamentarium for psoriasis.

Authors:  Egídio Freitas; Tiago Torres
Journal:  Drugs Context       Date:  2021-06-08

Review 10.  A New Venue of TNF Targeting.

Authors:  Sophie Steeland; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Int J Mol Sci       Date:  2018-05-11       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.